Clinical trial of Japanese-produced tetanus toxoid, diphtheria toxoid and acellular pertussis vaccine adsorbed [DTaP] vaccine in adolescents
Phase 3
- Conditions
- for active immunization against pertussis, diphtheria and tetanus
- Registration Number
- JPRN-jRCT2080222294
- Lead Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Age 11 or 12 years on the day of injection
(2) Received 3 or 4 doses of Japanese-produced tetanus toxoid, diphtheria toxoid and acellular pertussis vaccine absorbed [DTaP] vaccine, confirmed by checking immunization records
(3) Informed consent form signed and dated by the parent / legal representative
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method booster responses for the antibodies against pertussis toxoid, filamentous hemagglutinin, diphtheria toxoid and tetanus toxoid
- Secondary Outcome Measures
Name Time Method